Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18540379 | 0.87 | KDM1A (0.34) | KDM1AHSD17B1HSD17B2CYP3A4CYP2A6 | |
| SCHEMBL18537473 | 0.86 | GRM5 (0.31) | — | |
| SCHEMBL18540382 | 0.84 | PSMB5 (0.33) | PSMB5NR1H4FYN | |
| SCHEMBL18540375 | 0.83 | CYP11B1 (0.36) | KDM1AHSD17B1HSD17B2CYP3A4CYP11B1 | |
| SCHEMBL18540383 | 0.82 | HSD17B1 (0.39) | KDM1AHSD17B1HSD17B2CYP3A4CYP11B1 | |
| SCHEMBL18540377 | 0.82 | PIM1 (0.35) | KDM1AHSD17B1HSD17B2CYP2A6PSMB5 | |
| SCHEMBL18540387 | 0.82 | CYP2A6 (0.35) | CYP2A6PIM1PIM3PIM2 | |
| SCHEMBL5102492 | 0.78 | HTR1A (0.42) | CYP2A6METAP2 | |
| SCHEMBL18540381 | 0.76 | DHFR (0.36) | HSD17B1HSD17B2CYP11B1CYP11B2IDO1 | |
| SCHEMBL18537313 | 0.76 | KDM1A (0.34) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220093880-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2022-03-24 | — | — | US | disclosed |
| US-11211571-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220093880-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, LEF1, POU2F1 | KDM1A 326/4885HSD17B1 1490/4885HSD17B2 1944/4885 |
| US-11211571-B2 | Organometallic compound and organic light-emitting device including the same | CRY1, LEF1, POU2F1 | KDM1A 326/4885HSD17B1 1490/4885HSD17B2 1944/4885 |
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, LEF1, POU2F1 | KDM1A 326/4885HSD17B1 1490/4885HSD17B2 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.